BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, He L. Diagnosis and treatment of otomycosis in southern China. Mycoses 2019;62:1064-8. [PMID: 31368588 DOI: 10.1111/myc.12979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Chen Q, Chu H, Tao Y, Peng L, Zhou L, Liu L, Wu X. A Comparison of Triamcinolone Acetonide Econazole Cream and Nystatin Suspension in Treatment of Otomycosis. Laryngoscope 2021;131:E1640-6. [PMID: 33141477 DOI: 10.1002/lary.29190] [Reference Citation Analysis]
2 Jing R, Yang WH, Xiao M, Li Y, Zou GL, Wang CY, Li XW, Xu YC, Hsueh PR. Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China. J Microbiol Immunol Infect 2021:S1684-1182(21)00063-3. [PMID: 33839057 DOI: 10.1016/j.jmii.2021.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang S, Jin M, Hu S, Zhang Y, Zhou G. Administration of 1% topical voriconazole drops was effective and safe in the treatment of refractory otomycosis without tympanic membrane perforation. Ann Otol Rhinol Laryngol 2021;130:273-9. [PMID: 32772544 DOI: 10.1177/0003489420946783] [Reference Citation Analysis]
4 Kiakojuri K, Mahdavi Omran S, Roodgari S, Taghizadeh Armaki M, Hedayati MT, Shokohi T, Haghani I, Javidnia J, Kermani F, Badali H, Abastabar M. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis. Mycopathologia 2021;186:245-57. [PMID: 33718990 DOI: 10.1007/s11046-021-00537-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]